Opportunities and challenges in the era of molecularly targeted agents and radiation therapy

Steven H. Lin, Thomas J. George, Edgar Ben-Josef, Jeffrey Bradley, Kevin S. Choe, Martin J. Edelman, Chandan Guha, Sunil Krishnan, Theodore S. Lawrence, Quynh Thu Le, Bo Lu, Minesh Mehta, David Peereboom, Jann Sarkaria, Jinsil Seong, Dian Wang, Meng X. Welliver, C. Norman Coleman, Bhadrasain Vikram, Stephen YooChristine H. Chung

Research output: Contribution to journalReview article

34 Scopus citations

Abstract

The first annual workshop for preclinical and clinical development of radiosensitizers took place at the National Cancer Institute on August 8-9, 2012. Radiotherapy is one of the most commonly applied and effective oncologic treatments for solid tumors. It is well recognized that improved clinical efficacy of radiotherapy would make a substantive impact in clinical practice and patient outcomes. Advances in genomic technologies and high-throughput drug discovery platforms have brought a revolution in cancer treatment by providing molecularly targeted agents for various cancers. Development of predictive biomarkers directed toward specific subsets of cancers has ushered in a new era of personalized therapeutics. The field of radiation oncology stands to gain substantial benefit from these advances given the concerted effort to integrate this progress into radiation therapy. This workshop brought together expert clinicians and scientists working in various disease sites to identify the exciting opportunities and expected challenges in the development of molecularly targeted agents in combination with radiation therapy.

Original languageEnglish (US)
Pages (from-to)686-693
Number of pages8
JournalJournal of the National Cancer Institute
Volume105
Issue number10
DOIs
StatePublished - May 15 2013

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Lin, S. H., George, T. J., Ben-Josef, E., Bradley, J., Choe, K. S., Edelman, M. J., Guha, C., Krishnan, S., Lawrence, T. S., Le, Q. T., Lu, B., Mehta, M., Peereboom, D., Sarkaria, J., Seong, J., Wang, D., Welliver, M. X., Coleman, C. N., Vikram, B., ... Chung, C. H. (2013). Opportunities and challenges in the era of molecularly targeted agents and radiation therapy. Journal of the National Cancer Institute, 105(10), 686-693. https://doi.org/10.1093/jnci/djt055